Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Tirzepatide (GLP-1/GIP) Tirzepatide is a first-in-class dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist, providing synergistic metabolic effects for diabetes and obesity research
You've brought the peptide back to life
The dosing chart in units pre-calculates common scenarios, but knowing the formulas means you can verify any number and calculate custom doses that fall outside standard tables
Petersburg Institute of Bioregulation and Gerontology, where the compound was characterized as part of the broader Russian short-chain regulatory peptide research tradition
Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans
Current findings suggest that DSIP can influence corticotropin regulation, reduce somatostatin secretion, modulate stress responses, help stabilize blood pressure, adjust sleep activity, and affect pain sensitivity
US$ 26.45
US$ 24.28
US$ 25.16
